Anlon Healthcare Limited (NSE:AHCL)
India · Delayed Price · Currency is INR 127.03
-6.96 (-5.19%)
At close: Jan 20, 2026
Anlon Healthcare Revenue
Anlon Healthcare had revenue of 522.01M INR in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 1.44B. In the fiscal year ending March 31, 2025, Anlon Healthcare had annual revenue of 1.20B with 80.64% growth.
Revenue (ttm)
1.44B
Revenue Growth
+80.64%
P/S Ratio
4.77
Revenue / Employee
n/a
Employees
117
Market Cap
6.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.20B | 537.17M | 80.64% |
| Mar 31, 2024 | 666.16M | -464.64M | -41.09% |
| Mar 31, 2023 | 1.13B | 556.91M | 97.04% |
| Mar 31, 2022 | 573.89M | 414.09M | 259.14% |
| Mar 31, 2021 | 159.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 21.70B |
| Bajaj HealthCare | 6.11B |
| Aarey Drugs & Pharmaceuticals | 4.28B |
| NGL Fine-Chem | 4.08B |
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.20B |